FDA Brief

Company record

Bioporto Diagnostics A/S

0 FDA warning letters since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about Bioporto Diagnostics A/S.

Recalls

ReportedClassFirmProduct and reason
Aug 19 Class II Bioporto Diagnostics A/S
Device
ProNephro AKI (NGAL) Reagent Kit (100 tests). IVD Acute Kidney Injury Test System.
The use of a non-validated rework process for assay reagents which could lead to missed diagnosis of renal disease, inappropriate treatment decisions, or inappropriate monitoring of renal disease in intended users.